Kevin Patrick Danahy, Chief Commercial Officer: Pulse Biosciences PLSE Planned sale · Filed 25/09/18

Trade details

Type: Planned sale notice
Stock: Pulse Biosciences PLSE
Person: Kevin Patrick DanahyChief Commercial Officer
Planned sale date: 25/09/18
Filed: 25/09/18

$406.8K to be sold

Pulse Biosciences trades, last 26 weeks

What else happened in Pulse Biosciences around then

Filed or reported within 30 days of the trade day · 25/08/19~25/10/18

Kevin Patrick Danahy's recent trades

Kevin Patrick DanahyChief Commercial Officer
Sell10b5-1 planPulse Biosciences
Sell10b5-1 plan
Pulse Biosciences
PLSE
$118.2K
5,000 sh
$118.2K
Filed 02/23
Traded 02/18
Kevin Patrick DanahyChief Commercial Officer
Sell10b5-1 planPulse Biosciences
Sell10b5-1 plan
Pulse Biosciences
PLSE
$472.6K
20,000 sh
$472.6K
Filed 02/17
Traded 02/17
Kevin Patrick DanahyChief Commercial Officer
Sell10b5-1 planPulse Biosciences
Sell10b5-1 plan
Pulse Biosciences
PLSE
$470.6K
20,000 sh
$470.6K
Filed 02/17
Traded 02/13
Kevin Patrick DanahyChief Commercial Officer
Sell10b5-1 planPulse Biosciences
Sell10b5-1 plan
Pulse Biosciences
PLSE
$467.4K
20,000 sh
$467.4K
Filed 02/17
Traded 02/12
Kevin Patrick DanahyChief Commercial Officer
Planned sale10b5-1 planPulse Biosciences
Planned sale10b5-1 plan
Pulse Biosciences
PLSE
$1.3M
50,000 sh
$1.3M
Filed 02/12
Traded 02/12

Kevin Patrick Danahy, Chief Officer — plans to sell 25,000 sh of Pulse Biosciences PLSE · $406.8K · around 09/18 · 10b5-1 plan | Whalegun